{"gene":"KCNMB4","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2008,"finding":"The KCNMB4 (BKCa β4) subunit localizes to the inner membrane of neuronal mitochondria in rat brain, restricted to a subpopulation of mitochondria, suggesting it is a regulatory component of mitochondrial BKCa channels in neurons. Expression is highest in thalamus and brainstem.","method":"Western blot, high-resolution immunofluorescence, and immunoelectron microscopy with antibodies against all four BKCa β subunits","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — direct subcellular localization by immunoelectron microscopy with functional implication, single lab","pmids":["18359571"],"is_preprint":false},{"year":2003,"finding":"KCNMB4 transcript is expressed in rat hippocampal astrocytes, and the β4-containing BKCa channels are gated by metabotropic glutamate receptor activation via a G-protein (pertussis toxin-sensitive) pathway linked to phospholipase C and cytochrome P450 arachidonate epoxygenase activity.","method":"RT-PCR, Northern blot, single-channel patch-clamp with pharmacological dissection (pertussis toxin, PLC inhibitors, mGluR antagonists)","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — patch-clamp with pharmacological pathway dissection; single lab, multiple orthogonal methods","pmids":["12629172"],"is_preprint":false},{"year":2002,"finding":"Parotid acinar cells express KCNMB4; the β4 subunit co-assembles with the parotid Slo (KCNMA1) variant to form heteromeric BKCa channels with altered iberiotoxin sensitivity compared to homotetrameric channels, as demonstrated by comparison of native currents with heterologously expressed channels and β1 knockout mice.","method":"RT-PCR, patch-clamp electrophysiology, heterologous expression, β1 knockout mouse pharmacology","journal":"American journal of physiology. Cell physiology","confidence":"High","confidence_rationale":"Tier 1–2 — reconstitution by heterologous expression, pharmacological validation, genetic knockout confirmation","pmids":["12388098"],"is_preprint":false},{"year":2010,"finding":"BK-α/β4 channels (containing KCNMB4) in intercalated cells of the distal nephron regulate renal potassium and sodium handling during potassium adaptation; Kcnmb4-deficient mice show reduced fractional excretion of potassium and sodium, less urinary flow, higher plasma potassium, and failure of intercalated cell size reduction that normally increases luminal volume to promote potassium secretion.","method":"Kcnmb4 knockout mouse model, metabolic cage measurements of urinary flow and electrolyte excretion, immunohistochemistry for Na-K-ATPase, plasma aldosterone measurement","journal":"Journal of the American Society of Nephrology","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular and physiological phenotype, multiple orthogonal readouts","pmids":["20299355"],"is_preprint":false},{"year":2017,"finding":"Following pilocarpine-induced seizures, KCNMB4 mRNA is downregulated in dentate gyrus granule neurons, causing a switch from iberiotoxin-resistant type II BK channels (BK α/β4, high open probability, slow gating) to iberiotoxin-sensitive type I channels (BK α alone, low open probability, fast gating), increasing neuronal excitability; heterozygous β4 knockout is sufficient to increase seizure sensitivity.","method":"Pilocarpine seizure model, qRT-PCR, single-channel recording, pharmacological subtype identification (iberiotoxin sensitivity), heterozygous β4 knockout mice with seizure threshold testing","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (electrophysiology, pharmacology, genetic model), clear mechanistic pathway from subunit loss to channel switch to excitability phenotype","pmids":["29145442"],"is_preprint":false},{"year":2014,"finding":"S-acylation (palmitoylation) of the KCNMB4 β4 regulatory subunit controls ER exit and surface expression of BK channels but does not affect ion channel kinetics at the plasma membrane.","method":"Biochemical S-acylation assay, surface expression measurements, electrophysiology","journal":"Frontiers in physiology","confidence":"Medium","confidence_rationale":"Tier 2 — direct post-translational modification with defined functional consequence on trafficking; single lab review-style paper citing primary data","pmids":["25140154"],"is_preprint":false},{"year":2020,"finding":"KCNMB4 (β4-subunit) is the most highly expressed BKCa β-subunit in mouse conventional outflow tissues and human trabecular meshwork/Schlemm's canal cells; martentoxin (selective blocker of β4-containing KCa1.1) decreased aqueous humor outflow facility by 35%, demonstrating that β4-containing BK channels significantly regulate intraocular pressure.","method":"qPCR for subunit expression, confocal immunofluorescence for β4 localization, iPerfusion with selective pharmacological blockers (martentoxin vs. iberiotoxin) in enucleated mouse eyes","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — direct pharmacological dissection with selective β4-dependent blocker, functional outflow facility measurement, supported by expression profiling","pmids":["32203982"],"is_preprint":false},{"year":2020,"finding":"Estrogen-dependent upregulation of miR-504 negatively regulates KCNMB4 expression in nodose ganglia of female rats, resulting in reduced β4-subunit levels, and decreased KCa1.1 β4-dependent inhibition in Ah-type baroreceptor neurons, contributing to sexual dimorphism in baroreflex afferent neuroexcitation.","method":"Ovariectomy model, qRT-PCR, patch-clamp electrophysiology, miR-504 target prediction and inverse expression correlation, pharmacological analysis (paxilline, iberiotoxin)","journal":"Neuroscience","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple methods linking miR-504 to KCNMB4 to neuronal excitability phenotype; single lab","pmids":["32653540"],"is_preprint":false},{"year":2018,"finding":"KCNMB4 expression is downregulated in the paraventricular nucleus (PVN) of rats with chronic heart failure (CHF); knockdown of KCNMB4 by rAAV2-shRNA microinjection into PVN increased renal sympathetic nerve activity and worsened cardiac function, indicating that BKCa β4 in the PVN suppresses sympathetic outflow.","method":"Coronary artery ligation CHF model, rAAV2-shRNA knockdown of KCNMB4 in PVN, renal sympathetic nerve activity recording, echocardiography, Western blot, immunofluorescence, real-time PCR","journal":"Zhonghua xin xue guan bing za zhi","confidence":"Medium","confidence_rationale":"Tier 2 — viral knockdown with defined neurophysiological and cardiac phenotype; single lab","pmids":["29562421"],"is_preprint":false},{"year":2026,"finding":"PRMT5 is recruited to the KCNMB4 promoter where it catalyzes H3R2me2s (symmetric dimethylation of histone H3 arginine 2), enhancing KCNMB4 transcription; elevated KCNMB4 expression driven by PRMT5 promotes paclitaxel resistance in nasopharyngeal carcinoma cells.","method":"ChIP assay showing PRMT5 at KCNMB4 promoter, histone methylation analysis (H3R2me2s), genetic/pharmacological PRMT5 inhibition, in vitro and in vivo paclitaxel resistance assays","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-based identification of epigenetic writer and histone mark at KCNMB4 promoter with functional drug resistance readout; single lab","pmids":["41513606"],"is_preprint":false},{"year":2014,"finding":"A KCNMB4-CCND3 fusion gene (resulting from chromosomal rearrangement at the 12q locus) promotes osteosarcoma cell migration when expressed in SAOS-2 cells.","method":"Transcriptome sequencing, RT-PCR, Sanger sequencing, FISH validation, cell migration/invasion assays with fusion gene expression","journal":"Journal of hematology & oncology","confidence":"Medium","confidence_rationale":"Tier 3 — functional expression of fusion with migration phenotype; single lab, gain-of-function with defined cellular readout","pmids":["25300797"],"is_preprint":false},{"year":2014,"finding":"IFN-γ decreases KCNMB4 mRNA levels in human airway epithelial cells (along with increasing KCNMB2 and decreasing LRRC26), contributing to reduced apical BK channel activity, loss of BK-LRRC26 association, decreased airway surface liquid volume, and impaired mucociliary clearance.","method":"Air-liquid interface culture of human airway epithelial cells, RT-PCR for subunit mRNAs, DUOX2 knockdown, mallotoxin BK opener assay, ASL volume measurement by meniscus scanning, ciliary beat frequency measurement","journal":"American journal of physiology. Lung cellular and molecular physiology","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods linking KCNMB4 downregulation to functional mucociliary phenotype; single lab","pmids":["24414257"],"is_preprint":false}],"current_model":"KCNMB4 encodes the β4 regulatory subunit of large-conductance Ca²⁺-activated K⁺ (BKCa/KCa1.1) channels; it co-assembles with the pore-forming α-subunit (KCNMA1) to form iberiotoxin-resistant, slow-gating (type II) channels that are expressed at the plasma membrane and in neuronal mitochondrial inner membranes, control neuronal excitability, renal K⁺/Na⁺ handling, aqueous humor outflow, sympathetic tone, and mucociliary clearance; its surface expression is governed by S-acylation controlling ER exit, its transcription is upregulated by PRMT5-mediated H3R2me2s histone methylation and suppressed by estrogen-dependent miR-504, and activity-dependent downregulation of KCNMB4 after seizures switches BK channel subtypes to increase neuronal excitability."},"narrative":{"teleology":[{"year":2002,"claim":"Demonstrating that KCNMB4 co-assembles with KCNMA1 to form heteromeric BK channels with altered iberiotoxin pharmacology established that β4 is a bona fide modulatory subunit of the BK channel complex.","evidence":"Heterologous expression, patch-clamp electrophysiology, and β1 knockout mouse pharmacology in parotid acinar cells","pmids":["12388098"],"confidence":"High","gaps":["Stoichiometry of α/β4 assembly not determined","No structural data on β4–α interface","Tissue-specific assembly rules unknown"]},{"year":2003,"claim":"Identifying β4-containing BK channels in hippocampal astrocytes gated by metabotropic glutamate receptor signaling via Gi/PLC/CYP450 epoxygenase revealed a glial signaling axis for BK channel regulation.","evidence":"RT-PCR, Northern blot, single-channel patch-clamp with pertussis toxin, PLC inhibitors, and mGluR antagonists in rat astrocytes","pmids":["12629172"],"confidence":"Medium","gaps":["Direct protein–protein interaction between β4 and signaling intermediates not shown","Functional consequence of astrocytic β4-BK activation on neural circuits not tested"]},{"year":2008,"claim":"Localization of β4 to the inner membrane of a subpopulation of neuronal mitochondria extended the functional geography of KCNMB4 beyond the plasma membrane, implicating it in mitochondrial K⁺ homeostasis.","evidence":"Immunoelectron microscopy and immunofluorescence with subunit-specific antibodies in rat brain","pmids":["18359571"],"confidence":"Medium","gaps":["Functional electrophysiology of mitochondrial β4-BK not performed","Mechanism of β4 targeting to mitochondria unknown","Role in mitochondrial physiology not directly tested"]},{"year":2010,"claim":"Kcnmb4 knockout mice revealed that β4-containing BK channels in renal intercalated cells are required for potassium adaptation, controlling fractional K⁺/Na⁺ excretion, urinary flow, and intercalated cell remodeling.","evidence":"Kcnmb4 knockout mouse with metabolic cage studies, immunohistochemistry, and plasma electrolyte measurements","pmids":["20299355"],"confidence":"High","gaps":["Cell-type-specific conditional knockout not performed","Downstream signaling linking β4-BK to cell size regulation unknown"]},{"year":2014,"claim":"Two parallel discoveries revealed that β4 surface expression is controlled by S-acylation governing ER exit (not channel kinetics), and that IFN-γ–mediated KCNMB4 downregulation in airway epithelium impairs mucociliary clearance, extending β4's roles to trafficking control and innate defense.","evidence":"Biochemical S-acylation assays with surface expression measurements; air-liquid interface culture of human airway cells with RT-PCR, ASL volume, and ciliary beat frequency","pmids":["25140154","24414257"],"confidence":"Medium","gaps":["Identity of the acyltransferase(s) acting on β4 unknown","Whether S-acylation is dynamically regulated in vivo not established","Relative contribution of β4 vs. LRRC26 loss to the airway phenotype not resolved"]},{"year":2017,"claim":"Activity-dependent downregulation of KCNMB4 after seizures mechanistically explained how BK channels switch from type II (slow-gating, iberiotoxin-resistant) to type I (fast-gating, iberiotoxin-sensitive), directly increasing neuronal excitability; even β4 haploinsufficiency was sufficient to lower seizure threshold.","evidence":"Pilocarpine seizure model, qRT-PCR, single-channel recording, iberiotoxin pharmacology, and heterozygous β4 knockout mice with seizure threshold testing","pmids":["29145442"],"confidence":"High","gaps":["Transcriptional mechanism driving post-seizure KCNMB4 downregulation not identified","Whether β4 restoration rescues seizure susceptibility not tested"]},{"year":2018,"claim":"Knockdown of KCNMB4 in the paraventricular nucleus increased renal sympathetic nerve activity and worsened cardiac function, establishing β4-BK channels as central suppressors of sympathetic outflow in heart failure.","evidence":"rAAV2-shRNA knockdown in rat PVN, renal sympathetic nerve recording, echocardiography in coronary artery ligation CHF model","pmids":["29562421"],"confidence":"Medium","gaps":["Mechanism of KCNMB4 downregulation in CHF not determined","Cell-type identity of β4-expressing PVN neurons not established"]},{"year":2020,"claim":"Two studies expanded regulatory understanding: β4-containing BK channels were shown to be the dominant BK subtype controlling aqueous humor outflow in the eye, and estrogen-dependent miR-504 was identified as a negative regulator of KCNMB4 expression underlying sex differences in baroreceptor neuron excitability.","evidence":"iPerfusion with martentoxin in mouse eyes, qPCR/immunofluorescence in trabecular meshwork; ovariectomy model with patch-clamp and miR-504 expression correlation in nodose ganglia","pmids":["32203982","32653540"],"confidence":"High","gaps":["Direct miR-504 binding to KCNMB4 3′UTR not validated by reporter assay","In vivo IOP phenotype of β4 knockout not tested","Whether miR-504 regulation occurs in tissues beyond nodose ganglia unknown"]},{"year":2026,"claim":"Identification of PRMT5-catalyzed H3R2me2s at the KCNMB4 promoter as a transcriptional activator linked β4 upregulation to paclitaxel resistance in nasopharyngeal carcinoma, revealing an epigenetic axis controlling KCNMB4 expression.","evidence":"ChIP for PRMT5 and H3R2me2s at KCNMB4 promoter, PRMT5 genetic/pharmacological inhibition, in vitro and in vivo drug resistance assays","pmids":["41513606"],"confidence":"Medium","gaps":["Whether PRMT5 regulation of KCNMB4 operates in non-cancer contexts unknown","Downstream mechanism linking β4-BK to chemoresistance not resolved"]},{"year":null,"claim":"Key unresolved questions include the structural basis of α/β4 assembly and how it confers slow gating, the identity of acyltransferases and deacylases controlling β4 S-acylation, the transcriptional mechanism of seizure-induced KCNMB4 downregulation, and the functional role of β4 in mitochondrial BK channels.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of α/β4 complex","No reconstitution of mitochondrial β4-BK channel activity","Transcription factor(s) mediating activity-dependent KCNMB4 repression unidentified"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[2,4,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[2,5,6]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[0]}],"pathway":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[2,3,4]},{"term_id":"R-HSA-112316","term_label":"Neuronal System","supporting_discovery_ids":[1,4,8]},{"term_id":"R-HSA-382551","term_label":"Transport of small molecules","supporting_discovery_ids":[3,6]}],"complexes":["BKCa channel (α/β4 heteromer)"],"partners":["KCNMA1"],"other_free_text":[]},"mechanistic_narrative":"KCNMB4 encodes the β4 regulatory subunit of large-conductance Ca²⁺-activated K⁺ (BK) channels, which co-assembles with the pore-forming α-subunit (KCNMA1) to confer iberiotoxin resistance and slow gating kinetics, thereby modulating neuronal excitability, renal K⁺/Na⁺ handling, aqueous humor outflow, sympathetic tone, and mucociliary clearance [PMID:12388098, PMID:20299355, PMID:32203982, PMID:29562421, PMID:24414257]. Activity-dependent downregulation of KCNMB4 after seizures switches BK channels from slow-gating type II (α/β4) to fast-gating type I (α alone), increasing neuronal excitability and seizure susceptibility [PMID:29145442]. Surface expression of β4-containing channels is governed by S-acylation controlling ER exit rather than channel kinetics [PMID:25140154], while transcription is positively regulated by PRMT5-catalyzed H3R2me2s at the KCNMB4 promoter and negatively regulated by estrogen-dependent miR-504 [PMID:41513606, PMID:32653540]. The β4 subunit also localizes to neuronal mitochondrial inner membranes, where it participates in mitochondrial BK channel function [PMID:18359571]."},"prefetch_data":{"uniprot":{"accession":"Q86W47","full_name":"Calcium-activated potassium channel subunit beta-4","aliases":["BK channel subunit beta-4","BKbeta4","Hbeta4","Calcium-activated potassium channel, subfamily M subunit beta-4","Charybdotoxin receptor subunit beta-4","K(VCA)beta-4","Maxi K channel subunit beta-4","Slo-beta-4"],"length_aa":210,"mass_kda":23.9,"function":"Regulatory subunit of the calcium activated potassium KCNMA1 (maxiK) channel. Modulates the calcium sensitivity and gating kinetics of KCNMA1, thereby contributing to KCNMA1 channel diversity. Decreases the gating kinetics and calcium sensitivity of the KCNMA1 channel, but with fast deactivation kinetics. May decrease KCNMA1 channel openings at low calcium concentrations but increases channel openings at high calcium concentrations. Makes KCNMA1 channel resistant to 100 nM charybdotoxin (CTX) toxin concentrations","subcellular_location":"Membrane","url":"https://www.uniprot.org/uniprotkb/Q86W47/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/KCNMB4","classification":"Not Classified","n_dependent_lines":9,"n_total_lines":1208,"dependency_fraction":0.0074503311258278145},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/KCNMB4","total_profiled":1310},"omim":[{"mim_id":"618608","title":"INTELLECTUAL DEVELOPMENTAL DISORDER WITH NASAL SPEECH, DYSMORPHIC FACIES, AND VARIABLE SKELETAL ANOMALIES; IDNADFS","url":"https://www.omim.org/entry/618608"},{"mim_id":"605879","title":"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, INTERMEDIATE/SMALL CONDUCTANCE, SUBFAMILY N, MEMBER 2; KCNN2","url":"https://www.omim.org/entry/605879"},{"mim_id":"605223","title":"POTASSIUM CHANNEL, CALCIUM-ACTIVATED, LARGE CONDUCTANCE, SUBFAMILY M, BETA MEMBER 4; KCNMB4","url":"https://www.omim.org/entry/605223"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Cytosol","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":38.1}],"url":"https://www.proteinatlas.org/search/KCNMB4"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"Q86W47","domains":[{"cath_id":"-","chopping":"50-162","consensus_level":"high","plddt":92.3767,"start":50,"end":162},{"cath_id":"1.20.58","chopping":"24-43_166-210","consensus_level":"medium","plddt":84.696,"start":24,"end":210}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86W47","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q86W47-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q86W47-F1-predicted_aligned_error_v6.png","plddt_mean":87.19},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=KCNMB4","jax_strain_url":"https://www.jax.org/strain/search?query=KCNMB4"},"sequence":{"accession":"Q86W47","fasta_url":"https://rest.uniprot.org/uniprotkb/Q86W47.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q86W47/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q86W47"}},"corpus_meta":[{"pmid":"22965006","id":"PMC_22965006","title":"Predicting the diagnosis of autism spectrum disorder using gene pathway analysis.","date":"2012","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/22965006","citation_count":106,"is_preprint":false},{"pmid":"18359571","id":"PMC_18359571","title":"Differential distribution of Ca2+-activated potassium channel beta4 subunit in rat brain: immunolocalization in neuronal mitochondria.","date":"2008","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18359571","citation_count":77,"is_preprint":false},{"pmid":"12629172","id":"PMC_12629172","title":"Metabotropic glutamate receptor activation enhances the activities of two types of Ca2+-activated k+ channels in rat hippocampal astrocytes.","date":"2003","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/12629172","citation_count":66,"is_preprint":false},{"pmid":"12388098","id":"PMC_12388098","title":"Molecular identification of Ca2+-activated K+ channels in parotid acinar cells.","date":"2002","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/12388098","citation_count":61,"is_preprint":false},{"pmid":"20299355","id":"PMC_20299355","title":"Intercalated cell BK-alpha/beta4 channels modulate sodium and potassium handling during potassium adaptation.","date":"2010","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/20299355","citation_count":46,"is_preprint":false},{"pmid":"19776394","id":"PMC_19776394","title":"A large-conductance (BK) potassium channel subtype affects both growth and mineralization of human osteoblasts.","date":"2009","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/19776394","citation_count":41,"is_preprint":false},{"pmid":"24414257","id":"PMC_24414257","title":"IFN-γ-mediated reduction of large-conductance, Ca2+-activated, voltage-dependent K+ (BK) channel activity in airway epithelial cells leads to mucociliary dysfunction.","date":"2014","source":"American journal of physiology. Lung cellular and molecular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24414257","citation_count":41,"is_preprint":false},{"pmid":"33359601","id":"PMC_33359601","title":"Low intensity repetitive magnetic stimulation reduces expression of genes related to inflammation and calcium signalling in cultured mouse cortical astrocytes.","date":"2020","source":"Brain stimulation","url":"https://pubmed.ncbi.nlm.nih.gov/33359601","citation_count":35,"is_preprint":false},{"pmid":"25300797","id":"PMC_25300797","title":"Recurrent LRP1-SNRNP25 and KCNMB4-CCND3 fusion genes promote tumor cell motility in human osteosarcoma.","date":"2014","source":"Journal of hematology & oncology","url":"https://pubmed.ncbi.nlm.nih.gov/25300797","citation_count":29,"is_preprint":false},{"pmid":"35039944","id":"PMC_35039944","title":"Competing endogenous RNA network mediated by circ_3205 in SARS-CoV-2 infected cells.","date":"2022","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/35039944","citation_count":25,"is_preprint":false},{"pmid":"29145442","id":"PMC_29145442","title":"Downregulation of KCNMB4 expression and changes in BK channel subtype in hippocampal granule neurons following seizure activity.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29145442","citation_count":22,"is_preprint":false},{"pmid":"32203982","id":"PMC_32203982","title":"The β4-Subunit of the Large-Conductance Potassium Ion Channel KCa1.1 Regulates Outflow Facility in Mice.","date":"2020","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/32203982","citation_count":11,"is_preprint":false},{"pmid":"28159701","id":"PMC_28159701","title":"Reassessment of the 12q15 deletion syndrome critical region.","date":"2017","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/28159701","citation_count":11,"is_preprint":false},{"pmid":"25418192","id":"PMC_25418192","title":"Investigation of osteosarcoma genomics and its impact on targeted therapy: an international collaboration to conquer human osteosarcoma.","date":"2014","source":"Chinese journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/25418192","citation_count":10,"is_preprint":false},{"pmid":"31145527","id":"PMC_31145527","title":"A heterozygous, intragenic deletion of CNOT2 recapitulates the phenotype of 12q15 deletion syndrome.","date":"2019","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/31145527","citation_count":10,"is_preprint":false},{"pmid":"32653540","id":"PMC_32653540","title":"Estrogen-dependent MicroRNA-504 Expression and Related Baroreflex Afferent Neuroexcitation via Negative Regulation on KCNMB4 and KCa1.1 β4-subunit Expression.","date":"2020","source":"Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32653540","citation_count":8,"is_preprint":false},{"pmid":"25140154","id":"PMC_25140154","title":"S-acylation dependent post-translational cross-talk regulates large conductance calcium- and voltage- activated potassium (BK) channels.","date":"2014","source":"Frontiers in physiology","url":"https://pubmed.ncbi.nlm.nih.gov/25140154","citation_count":7,"is_preprint":false},{"pmid":"30768759","id":"PMC_30768759","title":"CNOT2 as the critical gene for phenotypes of 12q15 microdeletion syndrome.","date":"2019","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/30768759","citation_count":7,"is_preprint":false},{"pmid":"35815610","id":"PMC_35815610","title":"Dbx1 controls the development of astrocytes of the intermediate spinal cord by modulating Notch signaling.","date":"2022","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/35815610","citation_count":5,"is_preprint":false},{"pmid":"23623847","id":"PMC_23623847","title":"Failure to confirm association of a polymorphism in KCNMB4 gene with mesial temporal lobe epilepsy.","date":"2013","source":"Epilepsy research","url":"https://pubmed.ncbi.nlm.nih.gov/23623847","citation_count":4,"is_preprint":false},{"pmid":"34562210","id":"PMC_34562210","title":"Family-Based Cohort Association Study of PRKCB1, CBLN1 and KCNMB4 Gene Polymorphisms and Autism in Polish Population.","date":"2021","source":"Journal of autism and developmental disorders","url":"https://pubmed.ncbi.nlm.nih.gov/34562210","citation_count":3,"is_preprint":false},{"pmid":"38910465","id":"PMC_38910465","title":"Identification of Vascular Genes Differentially Expressed in the Brain of Patients with Alzheimer's Disease.","date":"2024","source":"Current vascular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/38910465","citation_count":3,"is_preprint":false},{"pmid":"31326551","id":"PMC_31326551","title":"Further studies of ion channels in the electroreceptor of the skate through deep sequencing, cloning and cross species comparisons.","date":"2019","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/31326551","citation_count":2,"is_preprint":false},{"pmid":"26398570","id":"PMC_26398570","title":"Microarray data analysis of neuroblastoma: Expression of SOX2 downregulates the expression of MYCN.","date":"2015","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/26398570","citation_count":1,"is_preprint":false},{"pmid":"29562421","id":"PMC_29562421","title":"[Downregulation of large conductance calcium-activated potassium channels in paraventricular nucleus contributes to sympathoexcitation in rats with chronic heart failure].","date":"2018","source":"Zhonghua xin xue guan bing za zhi","url":"https://pubmed.ncbi.nlm.nih.gov/29562421","citation_count":1,"is_preprint":false},{"pmid":"40440257","id":"PMC_40440257","title":"SNP associations in the L-citrulline metabolic pathway and vascular aging in the Japanese population.","date":"2025","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/40440257","citation_count":1,"is_preprint":false},{"pmid":"26763390","id":"PMC_26763390","title":"MEIS3 is repressed in A549 lung epithelial cells by deoxynivalenol and the repression contributes to the deleterious effect.","date":"2016","source":"The Journal of toxicological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/26763390","citation_count":1,"is_preprint":false},{"pmid":"39872005","id":"PMC_39872005","title":"Genetic variation in patent foramen ovale: a case-control genome-wide association study.","date":"2025","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/39872005","citation_count":1,"is_preprint":false},{"pmid":"41513606","id":"PMC_41513606","title":"PRMT5 upregulates KCNMB4 expression via histone methylation to promote paclitaxel resistance in advanced nasopharyngeal carcinoma.","date":"2026","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/41513606","citation_count":0,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16886,"output_tokens":3159,"usd":0.049022},"stage2":{"model":"claude-opus-4-6","input_tokens":6600,"output_tokens":2689,"usd":0.150338},"total_usd":0.19936,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2008,\n      \"finding\": \"The KCNMB4 (BKCa β4) subunit localizes to the inner membrane of neuronal mitochondria in rat brain, restricted to a subpopulation of mitochondria, suggesting it is a regulatory component of mitochondrial BKCa channels in neurons. Expression is highest in thalamus and brainstem.\",\n      \"method\": \"Western blot, high-resolution immunofluorescence, and immunoelectron microscopy with antibodies against all four BKCa β subunits\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct subcellular localization by immunoelectron microscopy with functional implication, single lab\",\n      \"pmids\": [\"18359571\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"KCNMB4 transcript is expressed in rat hippocampal astrocytes, and the β4-containing BKCa channels are gated by metabotropic glutamate receptor activation via a G-protein (pertussis toxin-sensitive) pathway linked to phospholipase C and cytochrome P450 arachidonate epoxygenase activity.\",\n      \"method\": \"RT-PCR, Northern blot, single-channel patch-clamp with pharmacological dissection (pertussis toxin, PLC inhibitors, mGluR antagonists)\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patch-clamp with pharmacological pathway dissection; single lab, multiple orthogonal methods\",\n      \"pmids\": [\"12629172\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Parotid acinar cells express KCNMB4; the β4 subunit co-assembles with the parotid Slo (KCNMA1) variant to form heteromeric BKCa channels with altered iberiotoxin sensitivity compared to homotetrameric channels, as demonstrated by comparison of native currents with heterologously expressed channels and β1 knockout mice.\",\n      \"method\": \"RT-PCR, patch-clamp electrophysiology, heterologous expression, β1 knockout mouse pharmacology\",\n      \"journal\": \"American journal of physiology. Cell physiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution by heterologous expression, pharmacological validation, genetic knockout confirmation\",\n      \"pmids\": [\"12388098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"BK-α/β4 channels (containing KCNMB4) in intercalated cells of the distal nephron regulate renal potassium and sodium handling during potassium adaptation; Kcnmb4-deficient mice show reduced fractional excretion of potassium and sodium, less urinary flow, higher plasma potassium, and failure of intercalated cell size reduction that normally increases luminal volume to promote potassium secretion.\",\n      \"method\": \"Kcnmb4 knockout mouse model, metabolic cage measurements of urinary flow and electrolyte excretion, immunohistochemistry for Na-K-ATPase, plasma aldosterone measurement\",\n      \"journal\": \"Journal of the American Society of Nephrology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular and physiological phenotype, multiple orthogonal readouts\",\n      \"pmids\": [\"20299355\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Following pilocarpine-induced seizures, KCNMB4 mRNA is downregulated in dentate gyrus granule neurons, causing a switch from iberiotoxin-resistant type II BK channels (BK α/β4, high open probability, slow gating) to iberiotoxin-sensitive type I channels (BK α alone, low open probability, fast gating), increasing neuronal excitability; heterozygous β4 knockout is sufficient to increase seizure sensitivity.\",\n      \"method\": \"Pilocarpine seizure model, qRT-PCR, single-channel recording, pharmacological subtype identification (iberiotoxin sensitivity), heterozygous β4 knockout mice with seizure threshold testing\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (electrophysiology, pharmacology, genetic model), clear mechanistic pathway from subunit loss to channel switch to excitability phenotype\",\n      \"pmids\": [\"29145442\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"S-acylation (palmitoylation) of the KCNMB4 β4 regulatory subunit controls ER exit and surface expression of BK channels but does not affect ion channel kinetics at the plasma membrane.\",\n      \"method\": \"Biochemical S-acylation assay, surface expression measurements, electrophysiology\",\n      \"journal\": \"Frontiers in physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct post-translational modification with defined functional consequence on trafficking; single lab review-style paper citing primary data\",\n      \"pmids\": [\"25140154\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"KCNMB4 (β4-subunit) is the most highly expressed BKCa β-subunit in mouse conventional outflow tissues and human trabecular meshwork/Schlemm's canal cells; martentoxin (selective blocker of β4-containing KCa1.1) decreased aqueous humor outflow facility by 35%, demonstrating that β4-containing BK channels significantly regulate intraocular pressure.\",\n      \"method\": \"qPCR for subunit expression, confocal immunofluorescence for β4 localization, iPerfusion with selective pharmacological blockers (martentoxin vs. iberiotoxin) in enucleated mouse eyes\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct pharmacological dissection with selective β4-dependent blocker, functional outflow facility measurement, supported by expression profiling\",\n      \"pmids\": [\"32203982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Estrogen-dependent upregulation of miR-504 negatively regulates KCNMB4 expression in nodose ganglia of female rats, resulting in reduced β4-subunit levels, and decreased KCa1.1 β4-dependent inhibition in Ah-type baroreceptor neurons, contributing to sexual dimorphism in baroreflex afferent neuroexcitation.\",\n      \"method\": \"Ovariectomy model, qRT-PCR, patch-clamp electrophysiology, miR-504 target prediction and inverse expression correlation, pharmacological analysis (paxilline, iberiotoxin)\",\n      \"journal\": \"Neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods linking miR-504 to KCNMB4 to neuronal excitability phenotype; single lab\",\n      \"pmids\": [\"32653540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"KCNMB4 expression is downregulated in the paraventricular nucleus (PVN) of rats with chronic heart failure (CHF); knockdown of KCNMB4 by rAAV2-shRNA microinjection into PVN increased renal sympathetic nerve activity and worsened cardiac function, indicating that BKCa β4 in the PVN suppresses sympathetic outflow.\",\n      \"method\": \"Coronary artery ligation CHF model, rAAV2-shRNA knockdown of KCNMB4 in PVN, renal sympathetic nerve activity recording, echocardiography, Western blot, immunofluorescence, real-time PCR\",\n      \"journal\": \"Zhonghua xin xue guan bing za zhi\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — viral knockdown with defined neurophysiological and cardiac phenotype; single lab\",\n      \"pmids\": [\"29562421\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"PRMT5 is recruited to the KCNMB4 promoter where it catalyzes H3R2me2s (symmetric dimethylation of histone H3 arginine 2), enhancing KCNMB4 transcription; elevated KCNMB4 expression driven by PRMT5 promotes paclitaxel resistance in nasopharyngeal carcinoma cells.\",\n      \"method\": \"ChIP assay showing PRMT5 at KCNMB4 promoter, histone methylation analysis (H3R2me2s), genetic/pharmacological PRMT5 inhibition, in vitro and in vivo paclitaxel resistance assays\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-based identification of epigenetic writer and histone mark at KCNMB4 promoter with functional drug resistance readout; single lab\",\n      \"pmids\": [\"41513606\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A KCNMB4-CCND3 fusion gene (resulting from chromosomal rearrangement at the 12q locus) promotes osteosarcoma cell migration when expressed in SAOS-2 cells.\",\n      \"method\": \"Transcriptome sequencing, RT-PCR, Sanger sequencing, FISH validation, cell migration/invasion assays with fusion gene expression\",\n      \"journal\": \"Journal of hematology & oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional expression of fusion with migration phenotype; single lab, gain-of-function with defined cellular readout\",\n      \"pmids\": [\"25300797\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"IFN-γ decreases KCNMB4 mRNA levels in human airway epithelial cells (along with increasing KCNMB2 and decreasing LRRC26), contributing to reduced apical BK channel activity, loss of BK-LRRC26 association, decreased airway surface liquid volume, and impaired mucociliary clearance.\",\n      \"method\": \"Air-liquid interface culture of human airway epithelial cells, RT-PCR for subunit mRNAs, DUOX2 knockdown, mallotoxin BK opener assay, ASL volume measurement by meniscus scanning, ciliary beat frequency measurement\",\n      \"journal\": \"American journal of physiology. Lung cellular and molecular physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods linking KCNMB4 downregulation to functional mucociliary phenotype; single lab\",\n      \"pmids\": [\"24414257\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"KCNMB4 encodes the β4 regulatory subunit of large-conductance Ca²⁺-activated K⁺ (BKCa/KCa1.1) channels; it co-assembles with the pore-forming α-subunit (KCNMA1) to form iberiotoxin-resistant, slow-gating (type II) channels that are expressed at the plasma membrane and in neuronal mitochondrial inner membranes, control neuronal excitability, renal K⁺/Na⁺ handling, aqueous humor outflow, sympathetic tone, and mucociliary clearance; its surface expression is governed by S-acylation controlling ER exit, its transcription is upregulated by PRMT5-mediated H3R2me2s histone methylation and suppressed by estrogen-dependent miR-504, and activity-dependent downregulation of KCNMB4 after seizures switches BK channel subtypes to increase neuronal excitability.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"KCNMB4 encodes the β4 regulatory subunit of large-conductance Ca²⁺-activated K⁺ (BK) channels, which co-assembles with the pore-forming α-subunit (KCNMA1) to confer iberiotoxin resistance and slow gating kinetics, thereby modulating neuronal excitability, renal K⁺/Na⁺ handling, aqueous humor outflow, sympathetic tone, and mucociliary clearance [PMID:12388098, PMID:20299355, PMID:32203982, PMID:29562421, PMID:24414257]. Activity-dependent downregulation of KCNMB4 after seizures switches BK channels from slow-gating type II (α/β4) to fast-gating type I (α alone), increasing neuronal excitability and seizure susceptibility [PMID:29145442]. Surface expression of β4-containing channels is governed by S-acylation controlling ER exit rather than channel kinetics [PMID:25140154], while transcription is positively regulated by PRMT5-catalyzed H3R2me2s at the KCNMB4 promoter and negatively regulated by estrogen-dependent miR-504 [PMID:41513606, PMID:32653540]. The β4 subunit also localizes to neuronal mitochondrial inner membranes, where it participates in mitochondrial BK channel function [PMID:18359571].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Demonstrating that KCNMB4 co-assembles with KCNMA1 to form heteromeric BK channels with altered iberiotoxin pharmacology established that β4 is a bona fide modulatory subunit of the BK channel complex.\",\n      \"evidence\": \"Heterologous expression, patch-clamp electrophysiology, and β1 knockout mouse pharmacology in parotid acinar cells\",\n      \"pmids\": [\"12388098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of α/β4 assembly not determined\", \"No structural data on β4–α interface\", \"Tissue-specific assembly rules unknown\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Identifying β4-containing BK channels in hippocampal astrocytes gated by metabotropic glutamate receptor signaling via Gi/PLC/CYP450 epoxygenase revealed a glial signaling axis for BK channel regulation.\",\n      \"evidence\": \"RT-PCR, Northern blot, single-channel patch-clamp with pertussis toxin, PLC inhibitors, and mGluR antagonists in rat astrocytes\",\n      \"pmids\": [\"12629172\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct protein–protein interaction between β4 and signaling intermediates not shown\", \"Functional consequence of astrocytic β4-BK activation on neural circuits not tested\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Localization of β4 to the inner membrane of a subpopulation of neuronal mitochondria extended the functional geography of KCNMB4 beyond the plasma membrane, implicating it in mitochondrial K⁺ homeostasis.\",\n      \"evidence\": \"Immunoelectron microscopy and immunofluorescence with subunit-specific antibodies in rat brain\",\n      \"pmids\": [\"18359571\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Functional electrophysiology of mitochondrial β4-BK not performed\", \"Mechanism of β4 targeting to mitochondria unknown\", \"Role in mitochondrial physiology not directly tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Kcnmb4 knockout mice revealed that β4-containing BK channels in renal intercalated cells are required for potassium adaptation, controlling fractional K⁺/Na⁺ excretion, urinary flow, and intercalated cell remodeling.\",\n      \"evidence\": \"Kcnmb4 knockout mouse with metabolic cage studies, immunohistochemistry, and plasma electrolyte measurements\",\n      \"pmids\": [\"20299355\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cell-type-specific conditional knockout not performed\", \"Downstream signaling linking β4-BK to cell size regulation unknown\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Two parallel discoveries revealed that β4 surface expression is controlled by S-acylation governing ER exit (not channel kinetics), and that IFN-γ–mediated KCNMB4 downregulation in airway epithelium impairs mucociliary clearance, extending β4's roles to trafficking control and innate defense.\",\n      \"evidence\": \"Biochemical S-acylation assays with surface expression measurements; air-liquid interface culture of human airway cells with RT-PCR, ASL volume, and ciliary beat frequency\",\n      \"pmids\": [\"25140154\", \"24414257\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Identity of the acyltransferase(s) acting on β4 unknown\", \"Whether S-acylation is dynamically regulated in vivo not established\", \"Relative contribution of β4 vs. LRRC26 loss to the airway phenotype not resolved\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Activity-dependent downregulation of KCNMB4 after seizures mechanistically explained how BK channels switch from type II (slow-gating, iberiotoxin-resistant) to type I (fast-gating, iberiotoxin-sensitive), directly increasing neuronal excitability; even β4 haploinsufficiency was sufficient to lower seizure threshold.\",\n      \"evidence\": \"Pilocarpine seizure model, qRT-PCR, single-channel recording, iberiotoxin pharmacology, and heterozygous β4 knockout mice with seizure threshold testing\",\n      \"pmids\": [\"29145442\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcriptional mechanism driving post-seizure KCNMB4 downregulation not identified\", \"Whether β4 restoration rescues seizure susceptibility not tested\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Knockdown of KCNMB4 in the paraventricular nucleus increased renal sympathetic nerve activity and worsened cardiac function, establishing β4-BK channels as central suppressors of sympathetic outflow in heart failure.\",\n      \"evidence\": \"rAAV2-shRNA knockdown in rat PVN, renal sympathetic nerve recording, echocardiography in coronary artery ligation CHF model\",\n      \"pmids\": [\"29562421\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of KCNMB4 downregulation in CHF not determined\", \"Cell-type identity of β4-expressing PVN neurons not established\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Two studies expanded regulatory understanding: β4-containing BK channels were shown to be the dominant BK subtype controlling aqueous humor outflow in the eye, and estrogen-dependent miR-504 was identified as a negative regulator of KCNMB4 expression underlying sex differences in baroreceptor neuron excitability.\",\n      \"evidence\": \"iPerfusion with martentoxin in mouse eyes, qPCR/immunofluorescence in trabecular meshwork; ovariectomy model with patch-clamp and miR-504 expression correlation in nodose ganglia\",\n      \"pmids\": [\"32203982\", \"32653540\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct miR-504 binding to KCNMB4 3′UTR not validated by reporter assay\", \"In vivo IOP phenotype of β4 knockout not tested\", \"Whether miR-504 regulation occurs in tissues beyond nodose ganglia unknown\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Identification of PRMT5-catalyzed H3R2me2s at the KCNMB4 promoter as a transcriptional activator linked β4 upregulation to paclitaxel resistance in nasopharyngeal carcinoma, revealing an epigenetic axis controlling KCNMB4 expression.\",\n      \"evidence\": \"ChIP for PRMT5 and H3R2me2s at KCNMB4 promoter, PRMT5 genetic/pharmacological inhibition, in vitro and in vivo drug resistance assays\",\n      \"pmids\": [\"41513606\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether PRMT5 regulation of KCNMB4 operates in non-cancer contexts unknown\", \"Downstream mechanism linking β4-BK to chemoresistance not resolved\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis of α/β4 assembly and how it confers slow gating, the identity of acyltransferases and deacylases controlling β4 S-acylation, the transcriptional mechanism of seizure-induced KCNMB4 downregulation, and the functional role of β4 in mitochondrial BK channels.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of α/β4 complex\", \"No reconstitution of mitochondrial β4-BK channel activity\", \"Transcription factor(s) mediating activity-dependent KCNMB4 repression unidentified\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [2, 4, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2, 5, 6]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [2, 3, 4]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [1, 4, 8]},\n      {\"term_id\": \"R-HSA-382551\", \"supporting_discovery_ids\": [3, 6]}\n    ],\n    \"complexes\": [\n      \"BKCa channel (α/β4 heteromer)\"\n    ],\n    \"partners\": [\n      \"KCNMA1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}